Project measures / variables set:   Koide2   capsaicin

ID, description, units MPD:35802   capsaicin   capsaicin solution consumption, percentage of baseline   [%]  
Measures
• concentration (µM):    • 0.5    • 1    • 4    • 7    • 10    • 15
Data set, strains Koide2   wild-derived Mishima   14 strains     sex: both     age: 8-12wks
Procedure nociception assay
Comparisoncontrol group vs. multiple treatment / dosage groups
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

Koide2 - capsaicin solution consumption, percentage of baseline




  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
concentration 5 772636.5843 154527.3169 183.2806 < 0.0001
sex 1 4054.9768 4054.9768 4.8095 0.0285
strain 13 376597.6703 28969.0516 34.3594 < 0.0001
concentration:sex 5 3398.0983 679.6197 0.8061 0.5452
concentration:strain 65 98205.9732 1510.8611 1.792 0.0001
sex:strain 13 29257.8397 2250.6031 2.6694 0.001
concentration:sex:strain 65 31718.1821 487.972 0.5788 0.9971
Residuals 1512 1274795.9007 843.119

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Koide2 35802 nociception assay (none) capsaicin solution consumption, percentage of baseline   [%]   concentration: 0.5 µM  capsaicin_05 wild-derived Mishima 14 both 8-12wks
Koide2 35803 nociception assay (none) capsaicin solution consumption, percentage of baseline   [%]   concentration: 1 µM  capsaicin_1 wild-derived Mishima 14 both 8-12wks
Koide2 35804 nociception assay (none) capsaicin solution consumption, percentage of baseline   [%]   concentration: 4 µM  capsaicin_4 wild-derived Mishima 14 both 8-12wks
Koide2 35805 nociception assay (none) capsaicin solution consumption, percentage of baseline   [%]   concentration: 7 µM  capsaicin_7 wild-derived Mishima 14 both 8-12wks
Koide2 35806 nociception assay (none) capsaicin solution consumption, percentage of baseline   [%]   concentration: 10 µM  capsaicin_10 wild-derived Mishima 14 both 8-12wks
Koide2 35807 nociception assay (none) capsaicin solution consumption, percentage of baseline   [%]   concentration: 15 µM  capsaicin_15 wild-derived Mishima 14 both 8-12wks